Aptar Pharma acquires Pulmotree
Pulmonary drug delivery, inhalation systems · Germanyacquired byAptar Pharma
Aptar Pharma acquires the German company Pulmotree, which develops the Kolibri platform for non-propellant-based liquid inhalers for targeted pulmonary drug delivery. The acquisition builds on a collaboration begun in 2024 and is intended to combine Kolibri with Aptar's regulatory, manufacturing and commercial capabilities.
- Buyer
- Aptar Pharma
- Target
- Pulmotree
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- Germany
- First reported
- 27/10/2026
- Source
- Aptar Pharma
Deal-Radar no. 44-025 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Aptar Pharma
So far this is the only transaction by Aptar Pharma published in the Deal-Radar. New deals are added every Monday.
Strategic and succession in Week 44/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 30 October 2026.